HOPPR

HOPPR has built a multi-modal foundation model trained on a broad dataset of medical images rather than a single-pathology classifier. This architecture allows the platform to generalize across imaging types — chest X-rays, musculoskeletal studies, and abdominal CTs — within a unified deployment, rather than requiring separate models for each use case.

The firm structures partnerships around utilization-based agreements tied to imaging volume processed through the platform, rather than fixed seat licenses. This aligns HOPPR's economics with clinical adoption metrics and reduces upfront capital expenditure for health-system partners, though it requires deeper technical integration with existing PACS and EHR systems.

Publicly documented deployments cover pulmonary imaging and musculoskeletal radiography, with the foundation model architecture designed to extend to additional modalities including CT and MRI. The platform's training corpus spans multiple modalities, though the firm prioritizes commercial rollout by clinical workflow rather than simultaneous modality coverage.

HOPPR is structured as an asset manager with its core asset being the proprietary AI platform. The firm generates returns through commercial licensing of the technology to healthcare enterprises, treating the model itself as the appreciating asset rather than managing a portfolio of external holdings.

The platform emerged from multi-institutional research collaborations, with foundational development work concentrated in North Carolina's Research Triangle. Commercialization efforts subsequently expanded to Chicago and the Bay Area, creating a distributed operational structure that spans clinical research hubs and technology talent markets.